408 related articles for article (PubMed ID: 14584417)
1. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
Semrád B
Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced QT-interval prolongation: considerations for clinicians.
Li EC; Esterly JS; Pohl S; Scott SD; McBride BF
Pharmacotherapy; 2010 Jul; 30(7):684-701. PubMed ID: 20575633
[TBL] [Abstract][Full Text] [Related]
3. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
[TBL] [Abstract][Full Text] [Related]
4. Short QT syndrome: a review.
Patel U; Pavri BB
Cardiol Rev; 2009; 17(6):300-3. PubMed ID: 19829181
[TBL] [Abstract][Full Text] [Related]
5. Sudden arrhythmia death syndrome: importance of the long QT syndrome.
Meyer JS; Mehdirad A; Salem BI; Kulikowska A; Kulikowski P
Am Fam Physician; 2003 Aug; 68(3):483-8. PubMed ID: 12924831
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying arrhythmogenesis in long QT syndrome.
Lankipalli RS; Zhu T; Guo D; Yan GX
J Electrocardiol; 2005 Oct; 38(4 Suppl):69-73. PubMed ID: 16226078
[TBL] [Abstract][Full Text] [Related]
8. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
9. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
Kecskeméti V
Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
[TBL] [Abstract][Full Text] [Related]
10. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
Fazekas T; Liszkai G
Orv Hetil; 2005 Mar; 146(10):451-60. PubMed ID: 15835343
[TBL] [Abstract][Full Text] [Related]
11. Short QT syndrome: pharmacological treatment.
Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
Shantsila E; Watson T; Lip GY
Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
[TBL] [Abstract][Full Text] [Related]
13. [Short QT Syndromes].
Schulze-Bahr E
Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
[TBL] [Abstract][Full Text] [Related]
14. [The pro-arrhythmic effects of anti-arrhythmia agents].
Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
[TBL] [Abstract][Full Text] [Related]
15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
16. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).
Hondeghem LM
Novartis Found Symp; 2005; 266():235-44; discussion 244-50. PubMed ID: 16050272
[TBL] [Abstract][Full Text] [Related]
17. [Sudden cardiac death and inherited repolarization disorders].
Gościńska K; Sredniawa B; Pasyk S
Przegl Lek; 2002; 59(7):523-6. PubMed ID: 12516242
[TBL] [Abstract][Full Text] [Related]
18. The genetic and clinical features of cardiac channelopathies.
Roberts JD; Gollob MH
Future Cardiol; 2010 Jul; 6(4):491-506. PubMed ID: 20608822
[TBL] [Abstract][Full Text] [Related]
19. Depolarization/repolarization, electrocardiographic abnormalities, and arrhythmias in cardiac channelopathies.
Marcus FI
J Electrocardiol; 2005 Oct; 38(4 Suppl):60-3. PubMed ID: 16226076
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
